OUR NEWS

January 2026

Wolfgang Löscher, PrevEp CSO, was named an inaugural Highly Ranked Scholar by ScholarGPS. Analyzing publication records, citations, and the quality of scholarly contributions of >30 million scholars worldwide, ScholarGPS celebrates Highly Ranked Scholars™ once a year for their exceptional performance. Based on his performance over the prior 5 years, Dr. Löscher ranked no. 1 in the field of epilepsy (https://scholargps.com/scholars/86699582678265/wolfgang-loscher).

December 2025

PrevEp Team reports a first-in-human administration of intransal seletracetam in a case of drug-resistant reflex epilepsy, at the American Epilepsy Society Annual Meeting:  Link

December 2025

img_publications

RECENT PUBLICATIONS

 
PrevEp006, intranasal seletracetam:
 
PrevEp004, iv topiramate:
 
PrevEp002, combination treatment of ceftriaxone, atorvastatin and levetiracetam:

 

April 2025

Eugen Trinka joins PrevEp as VP of Clinical Trials  

September 2023

PrevEp receives NINDS SBIR award 1R43NS132659 titled “Treatment of status epilepticus and refractory status epilepticus with intravenous topiramate”

September 2021

PrevEp receives NINDS SBIR award 1R43NS119081 titled “Network Pharmacology for epilepsy Prevention”